Immunoengineering can overcome the glycocalyx armour of cancer cells

免疫工程可以克服癌细胞的糖萼装甲

阅读:13
作者:Sangwoo Park, Marshall J Colville, Justin H Paek, Carolyn R Shurer, Arun Singh, Erica J Secor, Cooper J Sailer, Ling-Ting Huang, Joe Chin-Hun Kuo, Marc C Goudge, Jin Su, Minsoo Kim, Matthew P DeLisa, Sriram Neelamegham, Jan Lammerding, Warren R Zipfel, Claudia Fischbach, Heidi L Reesink, Matthew J P

Abstract

Cancer cell glycocalyx is a major line of defence against immune surveillance. However, how specific physical properties of the glycocalyx are regulated on a molecular level, contribute to immune evasion and may be overcome through immunoengineering must be resolved. Here we report how cancer-associated mucins and their glycosylation contribute to the nanoscale material thickness of the glycocalyx and consequently modulate the functional interactions with cytotoxic immune cells. Natural-killer-cell-mediated cytotoxicity is inversely correlated with the glycocalyx thickness of the target cells. Changes in glycocalyx thickness of approximately 10 nm can alter the susceptibility to immune cell attack. Enhanced stimulation of natural killer and T cells through equipment with chimeric antigen receptors can improve the cytotoxicity against mucin-bearing target cells. Alternatively, cytotoxicity can be enhanced through engineering effector cells to display glycocalyx-editing enzymes, including mucinases and sialidases. Together, our results motivate the development of immunoengineering strategies that overcome the glycocalyx armour of cancer cells.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。